
Seals playing computer games for science reveal how they navigate in murky water
One by one, Nick, Luca and Miro took their places in front of a screen at a German research lab to participate in a video game for science.
The task was straightforward. While viewing a simulation of moving through the ocean, the subjects would touch a red target on the left if they thought they were moving left, and a red target on the right if they thought they were moving right — an action these creatures learned by being rewarded with fish.
Using a series of dots streaming across a black screen that mimicked particles in murky water, researchers observed whether harbor seals used optic flow, or the movement of objects across one's field of vision, to determine the direction in which they are moving, according to a May 29 study published in the Journal of Experimental Biology.
Harbor seals are especially adept at navigating open water, which can be 'a strangely claustrophobic experience' for humans as our view drops to just a few centimeters, according to an article published in the Journal of Experimental Biology about the study.
Seals are known to use their highly sensitive and dexterous whiskers to navigate and hunt, but the role of visual perception is less studied.
The team designed three computer simulations. The first simulated a seal moving through the open sea with dots coming at them; the second simulated the sea floor passing beneath the seal; and the last simulated the sea surface above the seal's head, according to the article.
Three humans participated in the simulation for skill comparison, according to the study.
The seals' heading accuracy was 'comparable, but slightly inferior to the heading accuracy of humans and Rhesus macaques (a species of monkey),' according to the study.
'The (seals) were perfectly capable of determining which direction they were traveling in based simply on the dots streaming in their view; exactly as the cloudy water, seabed or water surface would appear to move when they are swimming,' the article said.
The research team included Laura-Marie Sandow, Ann-Kathrin Thimian, Markus Lappe and Frederike D. Hanke.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
10 hours ago
- Medscape
Small Ear-Wax Sample, Big Diagnostic Clues
A recent BBC report suggests that cerumen, commonly known as earwax, may harbor biomarkers to aid in the diagnosis and monitoring of conditions such as cancer, Alzheimer's disease, and metabolic disorders. Cerumen Profile The primary function of cerumen is to keep the external auditory canal clean and lubricated, preventing invasion by bacteria, fungi, and insects. Beyond this, cerumen may reflect systemic metabolism by concentrating a broader array of compounds than blood, urine, sweat, and tears. Its relative stability allows the accumulated cerumen to provide long-term snapshots of metabolic changes. Disease Associations Researchers have defined genetically determined wet and dry cerumen phenotypes. In the US, Caucasian, African American, and German women with wet cerumen faced roughly four times the risk of dying from breast cancer compared with Japanese and Taiwanese women with dry cerumen. The study found that Japanese women with breast cancer were more likely to carry the wet-cerumen allele than were healthy controls. However, large-scale studies in Germany, Australia, and Italy failed to confirm these associations. A recent analysis reported that patients with Ménière's disease had lower levels of three fatty acids in the cerumen compared with healthy controls — the first biomarker identified for that disorder. In a 2019 study led by Nelson Roberto Antoniosi Filho, PhD (Federal University of Goiás Goiânia in Brazil), researchers analyzed cerumen samples from 52 patients with lymphoma, carcinoma, or leukemia and 50 healthy volunteers, using a method that identifies volatile organic compounds (VOCs). The researchers identified 27 VOCs that served as diagnostic fingerprints for cancer, predicting the cancer status with 100% accuracy. The assay could not distinguish among cancer types, indicating that these VOCs represent a general response to malignant cells. Another investigation by the same group showed that cerumen analysis can detect metabolic disturbances in premalignant stages when cells exhibit dysplastic changes that may lead to cancer but remain nonmalignant, potentially enabling much earlier intervention. The team is also investigating whether metabolic alterations caused by neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, can be detected in the cerumen. Diagnostic Tool Antoniosi Filho and colleagues proposed that cancer, as a mitochondrial metabolic disorder, releases VOCs that accumulate in cerumen, allowing differentiation between healthy and cancerous individuals via an assay they call the cerumenogram. The aim was to develop a cerumenogram as a diagnostic tool to accurately predict certain cancers from a small cerumen sample. Clinical Adoption Hospital Amaral Carvalho in Jaú, São Paulo — a national reference center for oncology and bone marrow transplantation — has recently implemented cerumenograms for cancer diagnosis and monitoring. Future Directions An April 2025 paper in Scientific Reports by Antoniosi Filho concluded that the cerumenogram could: 1. Identify oncologic risk by detecting premalignant cells before cancer onset, introducing a novel screening modality 2. Show that mitochondrial impairment in premalignant cells — such as hypermetabolic inflammation and dysplasia — produces the same VOC biomarkers as malignant cells, distinct from those in benign lesions, opening new paths for risk management and early intervention 3. Correlate cerumenogram findings with established imaging techniques such as 2-deoxy-2-[fluorine-18] fluoro-D-glucose PET/CT (18F-FDG PET/CT) and gallium-68 PSMA PET/CT, demonstrating alignment with clinical results while offering a noninvasive, lower-cost alternative 4. Monitor treatment response and cancer remission, supporting assessment of therapeutic efficacy and cellular return to normal 5. Confirm metabolic indicators of malignancy to guide clinical decisions alongside imaging and biopsy 6. Drive the development of targeted therapies aimed at metabolites overproduced in malignant conditions. In conclusion, the cerumenogram may serve as a valuable assay for evaluating precancerous indicators, cancer progression, and remission, with the potential to reduce mortality, alleviate patient suffering, and lower disease-related costs. Congratulations to Nelson Roberto Antoniosi Filho, PhD, and his team.
Yahoo
a day ago
- Yahoo
Billionaire Burn Book: The Latest on President Trump and Elon Musk's War of Words
What started as a simmering policy disagreement has exploded into an all-out social media war between President Trump and Elon Musk — complete with personal insults, political threats, and even accusations tied to Jeffrey Epstein, the late financier and convicted sex offender. The once-powerful alliance between the president and the billionaire tech mogul has rapidly unraveled in public view, with both men trading blows online and off. Here's how the feud erupted — and why it matters. During an Oval Office meeting Thursday with German Chancellor Friedrich Merz, Trump took a swipe at Musk, saying he was 'very surprised' and 'very disappointed' by the billionaire's public criticism of his signature spending bill, the One Big Beautiful Bill Act. 'Elon and I had a great relationship. I don't know if we will anymore,' Trump told reporters in the Oval Office. Musk wasted no time firing back on X, claiming Trump wouldn't have won the election without him. 'Such ingratitude,' he added. Those comments only seemed to irritate the president more. Trump fired back on his own social media site, Truth Social, calling Musk 'crazy,' saying that the 'easiest way to save money' would be to 'terminate Elon's Governmental Subsidies and Contracts.' Back on X, Musk said: 'Go ahead, make my day.' He then announced that his aerospace company, SpaceX, would ground Dragon, the spacecraft NASA uses to service the International Space Station. This move poses a serious threat to the Trump administration's ability to bring astronauts and cargo back and forth between the International Space Station and Earth. As the feud continued to escalate, Musk even alleged that Trump's name is listed in classified files related to Epstein. 'Time to drop the really big bomb,' Musk wrote on X. '@realDonaldTrump is in the Epstein files. That is the real reason they have not been made public. Have a nice day, DJT!' Then, he reposted a comment calling for President Trump to be impeached and replaced by his Vice President, J.D. Vance. 'Yes,' Musk replied to the commenter's idea. Musk ignited the feud on Tuesday, slamming Trump's massive spending bill as a 'disgusting abomination,' citing government projections that it would significantly increase the federal deficit. By Wednesday afternoon, he was already urging lawmakers to 'kill the bill,' which still needs to clear the Senate. Trump initially brushed off the criticism, suggesting Musk's outrage stemmed from the repeal of an electric vehicle tax credit — a change the president claimed the Tesla CEO had known about 'from the beginning.' But Musk fired back, saying he'd never even seen the bill before it passed the House. 'False, this bill was never shown to me even once and was passed in the dead of night so fast that almost no one in Congress could even read it!' Musk posted on X. The rift marks a dramatic turn for two men who once appeared politically inseparable. Musk spent nearly $300 million to help elect Trump and quickly became one of his closest advisers. He was a regular presence on Air Force One, often appeared at the White House with his young son, and served as a high-profile symbol of the administration's tech-forward agenda. Just two months ago, Trump even bought a Tesla on the White House lawn — a display of loyalty as Musk's brand took a hit over his increasingly visible role in the administration. But last week, Musk abruptly stepped down and floated the idea of starting a new political party — the clearest sign yet that the alliance had fractured. Still, Musk is certainly not the first to leave Trump's inner circle. The former president has a long track record of high-profile breakups: Billionaire Peter Thiel distanced himself after the 2020 election, former Secretary of State Rex Tillerson was ousted after clashing with Trump over foreign policy, and even longtime fixer Michael Cohen turned critic following legal troubles. Like Musk, many of them were once close confidants who played key roles in shaping Trump's image. The post Billionaire Burn Book: The Latest on President Trump and Elon Musk's War of Words appeared first on Katie Couric Media.

Yahoo
a day ago
- Yahoo
Dr. Cockrell Joins Cutting-Edge Foot and Ankle Clinic in Nashville
Nashville-Davidson, June 05, 2025 (GLOBE NEWSWIRE) -- Nashville-Davidson, Tennessee - Cutting-Edge Foot and Ankle Clinic, led by podiatrists Dr. David Farnen and Dr. Yerusalem Lanier, along with nurse practitioner Morgan Hubble and physician assistant Rojin Abdullah, announced the addition of Dr. Gary Cockrell to its expanding and highly skilled medical staff. With convenient locations in Nashville and Brentwood, the practice continues its mission to provide advanced, comprehensive foot and ankle care to patients throughout the greater Middle Tennessee region. Dr. Cockrell brings more than 32 years of experience in podiatric medicine and surgery, making him one of the most seasoned specialists in the entire region. He is board-certified in foot and ankle surgery and holds diplomate status from the American Board of Foot and Ankle Surgery, underscoring his advanced surgical expertise. A native of Virginia, Dr. Cockrell earned a bachelor of science degree in animal science from Virginia Tech in 1979, with a minor in biology. He received his doctor of podiatric medicine degree from the California College of Podiatric Medicine in San Francisco in 1988. Following medical school, he completed a rigorous podiatric surgical residency at Baptist Memorial Hospital in Memphis-Georgetown, Tennessee, further honing his surgical skills and clinical expertise. Throughout his career, Dr. Cockrell has been recognized for clinical excellence and strong professional leadership. He received the Harry Casson Award for Outstanding Achievement, a notable honor in podiatry. He is also an active member of the American College of Foot and Ankle Surgeons and the American Podiatric Medical Association. Since 1995, Dr. Cockrell has served continuously on the Tennessee Podiatric Medical Association (TPMA) executive board, holding key roles including scientific chair, treasurer, secretary, vice president and president. He served two consecutive terms as TPMA president from 2001 to 2003, helping guide statewide initiatives to advance podiatric care and improve patient outcomes. In 2015, Dr. Cockrell became the first surgeon in Tennessee to use the Merete Medical Metafix PlantarMax tension-side fixation plate, a German-engineered device designed to improve surgical outcomes in bunion and plantar plate repairs. This innovative technology reflects his commitment to surgical advancements that promote better recovery and positive results. "We are thrilled to welcome Dr. Cockrell to our care team," said Dr. David Farnen, co-owner of Cutting-Edge Foot and Ankle Clinic. "His extensive experience, surgical innovation and patient-centered approach align perfectly with our mission to provide exceptional care to every patient." Dr. Cockrell is accepting new patients at both the Nashville and Brentwood clinics. He specializes in diabetic foot care, wound healing, sports injuries and advanced surgical interventions for complex foot and ankle conditions. His expertise ensures patients receive the highest standard of care for both routine and challenging foot health issues. Cutting-Edge Foot and Ankle Clinic is known for its use of advanced diagnostic tools and personalized podiatry treatment plans tailored to each patient's unique needs. The clinic offers a broad range of services, including minimally invasive procedures, regenerative medicine and custom orthotics. The collaborative team remains committed to delivering high-quality, patient-focused care in a welcoming, compassionate environment. Beyond treatment, the clinic emphasizes patient education about foot and ankle health, empowering individuals with knowledge about prevention, maintenance and treatment options. This holistic approach promotes improved mobility, reduces pain and improves overall quality of life. Whether addressing chronic conditions or acute injuries, the team guides patients every step of the way with expertise and compassion. For appointments or media inquiries, please contact: Cutting-Edge Foot And Ankle Clinic Nashville Location: 3443 Dickerson Pike, Suite 740 Nashville, TN 37207 Brentwood Location: 1001 Healthpark Drive, Suite 330 Brentwood, TN Phone: (615) 866-9639 Website: Hours: Monday-Friday, 8:00 AM - 5:00 PM About Cutting-Edge Foot And Ankle Clinic: Founded by Dr. David Farnen and Dr. Yerusalem Lanier, Cutting-Edge Foot And Ankle Clinic is a leading podiatric practice serving the Middle Tennessee area with locations in Nashville and Brentwood. The practice features a comprehensive team of healthcare providers including Morgan Hubble, MP and Rojin Abdullah, PA, delivering innovative and comprehensive foot and ankle care using the latest medical technologies and treatment approaches. ### For more information about Cutting Edge Foot And Ankle Clinic , contact the company here:Cutting Edge Foot And Ankle Clinic Dr. Yerusalem Lanier DPM615-866-9639yerulanier@ Dickerson Pike, Suite 740, Nashville, TN 37207 CONTACT: Dr. Yerusalem Lanier DPMError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data